Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

Delayed Quote. Delayed  - 09/23 05:35:24 pm
97.89 EUR   +0.06%
09/22 MERCK : and the Royal Health Awareness Society Partner to Advance Wo..
09/21 MERCK : Invests over € 50 million in Flagship Pharmaceutical Packagi..
09/21 GLOBAL AZO PIGM : Basf, Clariant, Lanxess, Eckart, EMD, Merck KGaA, ..
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Merck : and the Royal Health Awareness Society Partner to Advance Women's Health in Jordan

share with twitter share with LinkedIn share with facebook
share via e-mail
09/22/2016 | 08:13pm CEST

DARMSTADT, Germany, September 22, 2016 /PRNewswire/ --

  • New partnership under Healthy Women, Healthy Economies initiative facilitates women to overcome health barriers to economic participation 

Merck, a leading science and technology company, today announced its partnership with the Royal Health Awareness Society (RHAS) of Jordan to advance health awareness and education particularly on thyroid disease amongst Jordanian women. Women are five to eight times more likely to suffer from thyroid disorders than men[1]. This memorandum of understanding and its resulting policies, which has been signed today, will support women's health and well-being in Jordan, helping women to be more active participants in their local economies.

     (Photo: http://photos.prnewswire.com/prnh/20160922/410985 )

"We are excited about our new partnership with Merck, which opens new horizons for RHAS to scale up and expand its outreach with a particular focus on women," Hanin Odeh, Director General of RHAS, commented on the signing. "Through this initiative, we are not only helping women look after the health of their children and families better, but more importantly, ensuring that women are looking after their own health. No doubt, if women are not healthy, we are jeopardizing our country's potential on various levels. We are glad that we could benefit from Merck's experience in this area, and adapt scientific and tested approaches, towards a healthier Jordan."

The memorandum is part of the global Healthy Women, Healthy Economies initiative, an innovative public-private partnership that explicitly links the issue of women's health and well-being with economic growth. The partnership will focus on developing a thyroid awareness campaign through expanding the Healthy Community Clinic program under RHAS' umbrella. This campaign aims to reach patients, most of whom are women, and health practitioners to promote healthy lifestyles, raise awareness on the importance of diagnosis and treatment of thyroid disease, and it will lay the ground work for further programs addressing other non-communicable diseases that disproportionately affect women.

"Advocating for better health, and especially women's health, creates a ripple effect, uplifting entire families, communities and future generations. We are proud to partner with RHAS to expand the Healthy Women, Healthy Economies initiative into Jordan. When women do better, communities become stronger and this reflects favourably on economies," said Belén Garijo, Member of the Executive Board and CEO Healthcare at Merck.

This memorandum is now the second of its kind signed by Merck under the program, following a 2015 partnership with the Philippine Department of Health and Philippine Thyroid Association. Healthy Women, Healthy Economies is an innovative public-private partnership under the auspices of the Asia Pacific Economic Cooperation, Merck, and the U.S. and Philippine governments that explicitly links the issue of women's health and well-being with economic growth. Merck pursues three strategic spheres of corporate responsibility, namely health, environment and culture. Healthy Women, Healthy Economies brings to life Merck's heritage of corporate responsibility and long-term vision to tackle big issues in health, like gender equality in the workforce and access to high-quality health solutions.

Healthy Women, Healthy Economies brings together the evidence about women's health and well-being and its impact on economic growth with the best practices that governments, employers and non-governmental organizations can follow. It aims to identify and implement policies that advance women's health and well-being to increase their economic participation in the societies they live in.


  1. According to the American Thyroid Association http://bit.ly/1X9oSBf

About RHAS 

The Royal Health Awareness Society was established in 2005 under the direction of Her Majesty Queen Rania Al-Abdullah to promote health awareness and to empower Jordanians to adopt healthy lifestyles and behaviors. To achieve its mission, RHAS adopts a comprehensive approach, through implementing preventative public health and safety programs based on the right to health for all, targeting school children, youth and the community at large.  

All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to http://www.merckgroup.com/subscribe  to register online, change your selection or discontinue this service.

About Merck 

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life - from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck generated sales of € 12.85 billion in 66 countries.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

     (Logo: http://photos.prnewswire.com/prnh/20151207/293543LOGO )

     (Logo: http://photos.prnewswire.com/prnh/20151019/278051LOGO )

© PR Newswire, source India Press Releases

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on MERCK KGAA
09/22 MERCK : and the Royal Health Awareness Society Partner to Advance Women's Health..
09/21 MERCK : Invests over € 50 million in Flagship Pharmaceutical Packaging Building ..
09/21 GLOBAL AZO PIGMENTS MARKET 2016 : Basf, Clariant, Lanxess, Eckart, EMD, Merck KG..
09/21 MERCK : Angola Receives 4 Million Praziquantel Tablets
09/20 MERCK : Prexton successfully completes phase 1 Parkinson's disease trial
09/19 MERCK : New Steritest™ Symbio Pump Accessories Enable Faster, Safer Steril..
09/16 MERCK : Presents New Data Examining Durable Efficacy with Investigational Cladri..
09/15 MERCK : Announces 2016 Recipients of € 1 Million Grant for Multiple Sclerosis In..
09/15 MERCK : Findings from Merck KGaA Broaden Understanding of Granular Matter Resear..
09/15 MERCK : "From Glitter to Glamour" – The Merck Pigment Innovation Ronastar®..
More news
Sector news : Specialty & Advanced Pharmaceuticals
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- 2nd Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira
09/23 Endo International CEO steps down, Campanelli named successor
09/23DJSHIRE : Files 8K - Direct Or Off-Balance Sheet Financial Obligation
More sector news : Specialty & Advanced Pharmaceuticals
News from SeekingAlpha
08/19 ALPHA FROM EQUAL-WEIGHTING : A Look At Materials
08/10 Bristol's Opdivo Fall-Out Brings Others Into Play
08/05 Merck KGaA's (MKGAF) CEO Stefan Oschmann on Q2 2016 Results - Earnings Call T..
08/04 Merck KGaA reports Q2 results
07/18 Merck's marketing application for Cladribine tablets accepted for review in E..
Financials (€)
Sales 2016 15 041 M
EBIT 2016 3 285 M
Net income 2016 1 546 M
Debt 2016 10 800 M
Yield 2016 1,25%
P/E ratio 2016 25,90
P/E ratio 2017 22,47
EV / Sales 2016 1,56x
EV / Sales 2017 1,39x
Capitalization 12 652 M
More Financials
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 104 €
Spread / Average Target 6,7%
Consensus details
EPS Revisions
More Estimates Revisions
Stefan Oschmann Chief Executive Officer
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Crocifissa Attardo Member-Supervisory Board
Mechthild Auge Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA9.29%14 203
ABBVIE INC9.69%105 823
BIOGEN INC2.03%68 493
KYOWA HAKKO KIRIN CO L..-14.44%9 295
More Results